SearchDictionaryMobileLogin

Greg Rossi Selected Research

Anemia

10/2007Pharmacokinetic evaluation of darbepoetin alfa for the treatment of pediatric patients with chemotherapy-induced anemia.
10/2007A randomized, open-label, multicenter trial of immediate versus delayed intervention with darbepoetin alfa for chemotherapy-induced anemia.
10/2007Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks.
06/2007A randomized, controlled trial comparing darbepoetin alfa correction/maintenance dosing with weekly dosing for treating chemotherapy-induced anemia.
06/2007Efficacy and safety of every-2-week darbepoetin alfa in patients with anemia of cancer: a controlled, randomized, open-label phase II trial.
05/2006Randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia: the 20030125 Study Group Trial.
02/2006Randomized, double-blind, active-controlled trial of every-3-week darbepoetin alfa for the treatment of chemotherapy-induced anemia.
12/2005Treatment of chemotherapy-induced anemia in breast cancer: results of a randomized controlled trial of darbepoetin alfa 200 microg every 2 weeks versus epoetin alfa 40,000 U weekly.
01/2004A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer.
11/2003A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia.

Articles by Research Topic

Disease

10Anemia
10/2007 - 11/2003
2Neoplasms (Cancer)
06/2007 - 01/2004
1Breast Neoplasms (Breast Cancer)
12/2005
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2005

Drug/Important Bio-Agent (IBA)

10darbepoetin alfa (Aranesp)FDA Link
10/2007 - 11/2003
5Epoetin Alfa (Epogen)FDA Link
05/2006 - 11/2003

Therapy/Procedure

9Drug Therapy (Chemotherapy)
10/2007 - 11/2003